The novel Coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2 virus continues to challenge scientists to find therapeutic treatments to combat the virus and to develop rapid and reliable methods for detection of the virus. Our team aims to contribute to both of these research areas over the next two years. Several Canadian research groups have asked us to test potential antiviral agents (including small peptides, aptamers, interleukins, and photosensitive virucidal dyes) in VERO E6 cell culture infected with COVID-19.
Join a thriving innovation ecosystem. Subscribe now